These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 446909)

  • 1. Methyl 2-tetradecylglycidate, an orally effective hypoglycemic agent that inhibits long chain fatty acid oxidation selectively.
    Tutwiler GF; Mohrbacher R; Ho W
    Diabetes; 1979 Mar; 28(3):242-8. PubMed ID: 446909
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)--an orally effective hypoglycemic agent.
    Tutwiler GF; Kirsch T; Mohrbacher RJ; Ho W
    Metabolism; 1978 Oct; 27(10):1539-56. PubMed ID: 692381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesis.
    Tutwiler GF; Dellevigne P
    J Biol Chem; 1979 Apr; 254(8):2935-41. PubMed ID: 429328
    [No Abstract]   [Full Text] [Related]  

  • 4. Alkylglycidic acids: potential new hypoglycemic agents.
    Ho W; Tutwiler GF; Cottrell SC; Morgans DJ; Tarhan O; Mohrbacher RJ
    J Med Chem; 1986 Nov; 29(11):2184-90. PubMed ID: 3783579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802) (preliminary communication).
    Tutwiler GF; Ryzlak MT
    Life Sci; 1980 Feb; 26(5):393-7. PubMed ID: 7366330
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the oral hypoglycemic agent 2-tetradecylglycidic acid on fatty acid oxidation in suckling rats in vivo and in perfused liver.
    Frost SC; Wells MA
    Arch Biochem Biophys; 1981 Oct; 211(2):547-55. PubMed ID: 7305389
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-Tetradecylglycidic acid.
    Tutwiler GF; Ho W; Mohrbacher RJ
    Methods Enzymol; 1981; 72():533-51. PubMed ID: 7311851
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of oral hypoglycemic agent methylpalmoxirate on exercise capacity of streptozocin diabetic rats.
    Young JC; Treadway JL; Fader EI; Caslin RF
    Diabetes; 1986 Jul; 35(7):744-8. PubMed ID: 3721061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial carnitine palmitoyl transferase A in vivo with methyl 2-tetradecylglycidate (methyl palmoxirate) and its relationship to ketonemia and glycemia.
    Tutwiler GF; Brentzel HJ; Kiorpes TC
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):288-96. PubMed ID: 3969383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methyl palmoxirate, an oral hypoglycemic agent, on epinephrine-induced hyperglycemia in the rat.
    Tutwiler GF; Joseph J; Wallace N
    Biochem Pharmacol; 1985 Jun; 34(12):2217-20. PubMed ID: 4004943
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the oral hypoglycemic agent methyl palmoxirate on exercise capacity of rats.
    Young JC; Bryan JE; Constable SH; Tutwiler GF; Holloszy JO
    Can J Physiol Pharmacol; 1984 Jul; 62(7):815-8. PubMed ID: 6498613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate on fatty acid and glucose metabolism in perfused rat hearts determined using iodine-125 16-iodohexadecanoate.
    Sherratt HS; Gatley SJ; DeGrado TR; Ng CK; Holden JE
    Biochem Biophys Res Commun; 1983 Dec; 117(3):653-7. PubMed ID: 6667268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatic lipogenesis by 2-tetradecylglycidic acid.
    McCune SA; Nomura T; Harris RA
    Lipids; 1979 Oct; 14(10):880-2. PubMed ID: 502765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhibition of fatty acid oxidation on neonatal liver carnitine content.
    Frost SC; Wells MA
    Biochem J; 1982 Jun; 204(3):861-3. PubMed ID: 7126171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver.
    Ide T; Ontko JA
    J Biol Chem; 1981 Oct; 256(20):10247-55. PubMed ID: 7287708
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoglycaemic and hypoketonaemic effects of single and repeated oral doses of methyl palmoxirate (methyl 2-tetradecylglycidate) in streptozotocin/alloxan-induced diabetic dogs.
    Tuman RW; Tutwiler GF; Joseph JM; Wallace NH
    Br J Pharmacol; 1988 May; 94(1):130-6. PubMed ID: 3401631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in starved and alloxan-diabetic rats.
    Caterson ID; Fuller SJ; Randle PJ
    Biochem J; 1982 Oct; 208(1):53-60. PubMed ID: 7159398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of methyl-2-tetradecylglycidate (McNeil 3716) on heart mitochondrial metabolism in rats.
    Bachmann E; Weber E; Zbinden G
    Biochem Pharmacol; 1984 Jun; 33(12):1947-50. PubMed ID: 6732853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.
    Vaartjes WJ; De Haas CG; Haagsman HP
    Biochem Pharmacol; 1986 Dec; 35(23):4267-72. PubMed ID: 3790153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conclusive evidence that very-long-chain fatty acids are oxidized exclusively in peroxisomes in human skin fibroblasts.
    Jakobs BS; Wanders RJ
    Biochem Biophys Res Commun; 1991 Aug; 178(3):842-7. PubMed ID: 1872864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.